This roundtable addressed several questions concerning how payments are handled today, followed by recommendations for improving the payment process in the future:
- How do we address the differences in the level of payment by site?
- What issues do we have with Medicare payment?
- What issues do we have with the off-label use of pharmaceuticals?
- How should research be paid?
- How do we pay for survivorship, psychosocial issues, and end of life issues?
- How can we pay for cost effectiveness?
- How do we pay for quality?
- What is the patient responsibility for payment?
After the panelists addressed each of these questions, we posed the question, “If you could change payment policy, what would you do?”
Moderator:
- Peter D. Eisenberg, M.D., FACP, California Cancer Care, Inc.
Panelists:
- Michael Kolodziej, M.D., Medical Director, US Oncology, Inc
- Lee N. Newcomer, M.D., Senior Vice President, Oncology, United Healthcare
- William Rogers, M.D., FACEP, Medical Officer, Office of the Administrator, Centers for Medicaid and Medicare Services
Related Insights
31 December 2024
Foley Viewpoints
SEC Enforcement Action Against Church & Dwight Director: Lessons for Outside Directors
The SEC’s settlement with James R. Craigie, former CEO, chairman, and director of Church & Dwight Co. Inc., for violating proxy disclosure rules by standing for election as an independent director without disclosing his close personal friendship with a senior Church & Dwight executive has caused consternation in the legal community regarding when a friendship jeopardizes director independence under stock exchange rules.
31 December 2024
Manufacturing Industry Advisor
The State of the Law of Requirements Contracts
Amid increasing pressure on supply chains across the globe, multiple recent court opinions have disrupted the law of requirements contracts.
30 December 2024
Foley Viewpoints
Controlling Entities to Dealer Contracts Subject to Puerto Rico’s Law 75 May Be Liable for Tortious Interference
Plaintiffs asserting claims for tortious interference of contracts covered by Puerto Rico’s Dealer’s Contracts Act, commonly known as Law 75, may automatically satisfy one element of such a claim. Law 75 regulates relationships between distributors and manufacturers.